Top Markets
Coin of the day
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Rang în acțiuni #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Preț acțiune
$0.88012714
Capitalizare de piață
$439.58M
Schimbare (1 zi)
-4.01%
Schimbare (1 an)
1,130.75%
Țară
FR
Tranzacționează Valerio Therapeutics S.A. (ALVIO)

Categorie

Istoricul spliturilor pentru Valerio Therapeutics S.A. (ALVIO)
Acțiunea Valerio Therapeutics S.A. (simbol: ALVIO) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Sep 01, 2026.
O acțiune ALVIO cumpărată înainte de Sep 01, 2026 este echivalentă astăzi cu 0 acțiuni ALVIO.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH